MedTrace Logo

Increased Risk of VTE and Higher Hypercoagulability in Patients Recovered in ICU and in Medical Ward for COVID-19

NCT04359212 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2020-09-17

No results posted yet for this study

Summary

The aim of this study is to verify if patients admitted to hospital in a medical division and in the intensive care unit for a COVID-19 infection are at higher risk of developing a VTE complication and if they actually present an increased hypercoagulable state.

Conditions

  • COVID-19 Disease
  • Thromboembolism, Venous

Interventions

DRUG

thromboprophylaxis with low-molecular-weight heparin or fondaparinux

thromboprophylaxis with low-molecular-weight heparin or fondaparinux

Sponsors & Collaborators

  • Azienda Ospedaliera di Padova

    collaborator OTHER

  • Quovadis Associazione

    lead OTHER

Principal Investigators

  • Paolo Simioni, MD · Department of Medicine, University of Padua (I)

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-01
Primary Completion
2020-06-30
Completion
2020-07-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04359212 on ClinicalTrials.gov